Proteomic Analysis of Restored Insulin Production and Trafficking in Obese Diabetic Mouse Pancreatic Islets Following Euglycemia
- PMID: 31317746
- DOI: 10.1021/acs.jproteome.9b00160
Proteomic Analysis of Restored Insulin Production and Trafficking in Obese Diabetic Mouse Pancreatic Islets Following Euglycemia
Abstract
For the treatment of patients with prediabetes or diabetes, clinical evidence has emerged that β-cell function can be restored by glucose-lowering therapeutic strategies. However, little is known about the molecular mechanisms underlying this functional adaptive behavior of the pancreatic β-cell. This study examines the dynamic changes in protein expression and phosphorylation state associated with (pro)insulin production and secretory pathway function mediated by euglycemia to induce β-cell rest in obese/diabetic db/db islet β-cells. Unbiased quantitative profiling of the protein expression and phosphorylation events that occur upon β-cell adaption during the transition from hyperglycemia to euglycemia was assessed in isolated pancreatic islets from obese diabetic db/db and wild-type (WT) mice using quantitative proteomics and phosphoproteomics together with bioinformatics analysis. Dynamic changes in the expression and phosphorylation of proteins associated with pancreatic β-cell (pro)insulin production and complementary regulated-secretory pathway regulation were observed in obese diabetic db/db islets in a hyperglycemic environment, relative to WT mouse islets in a normal euglycemic environment, that resolved when isolated db/db islets were exposed to euglycemia for 12 h in vitro. By similarly treating WT islets in parallel, the effects of tissue culture could be mostly eliminated and only those changes associated with resolution by euglycemia were assessed. Among such regulated protein phosphorylation-dependent signaling events were those associated with COPII-coated vesicle-dependent ER exit, ER-to-Golgi trafficking, clathrin-coat disassembly, and a particular association for the luminal Golgi protein kinase, FAM20C, in control of distal secretory pathway trafficking, sorting, and granule biogenesis. Protein expression and especially phosphorylation play key roles in the regulation of (pro)insulin production, correlative secretory pathway trafficking, and the restoration of β-cell secretory capacity in the adaptive functional β-cell response to metabolic demand, especially that mediated by glucose.
Keywords: ER homeostasis; ER-to-Golgi trafficking; d/d; euglycemia; insulin; insulin biosynthesis; mass spectrometry; obesity; pancreatic islet β-cell; phosphoproteomics; secretory pathway; translation; type 2 diabetes; β-cell rest.
Similar articles
-
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production.Biomolecules. 2022 Feb 20;12(2):335. doi: 10.3390/biom12020335. Biomolecules. 2022. PMID: 35204835 Free PMC article. Review.
-
Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice.Mol Cell Proteomics. 2020 Jun;19(6):971-993. doi: 10.1074/mcp.RA119.001882. Epub 2020 Apr 7. Mol Cell Proteomics. 2020. PMID: 32265294 Free PMC article.
-
Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.Diabetologia. 2019 Dec;62(12):2273-2286. doi: 10.1007/s00125-019-05008-3. Epub 2019 Oct 17. Diabetologia. 2019. PMID: 31624901
-
[6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb/db type 2 diabetic mice.BMC Complement Altern Med. 2017 Aug 9;17(1):395. doi: 10.1186/s12906-017-1903-0. BMC Complement Altern Med. 2017. PMID: 28793909 Free PMC article.
-
Pancreatic beta cell ER export in health and diabetes.Front Endocrinol (Lausanne). 2023 Apr 21;14:1155779. doi: 10.3389/fendo.2023.1155779. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152949 Free PMC article. Review.
Cited by
-
Optimized protocol for shotgun label-free proteomic analysis of pancreatic islets.Biol Methods Protoc. 2024 Jan 25;9(1):bpae003. doi: 10.1093/biomethods/bpae003. eCollection 2024. Biol Methods Protoc. 2024. PMID: 38405023 Free PMC article. Review.
-
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production.Biomolecules. 2022 Feb 20;12(2):335. doi: 10.3390/biom12020335. Biomolecules. 2022. PMID: 35204835 Free PMC article. Review.
-
Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications.Front Mol Biosci. 2021 Dec 20;8:790172. doi: 10.3389/fmolb.2021.790172. eCollection 2021. Front Mol Biosci. 2021. PMID: 34988120 Free PMC article. Review.
-
Proteomic pathways to metabolic disease and type 2 diabetes in the pancreatic islet.iScience. 2021 Sep 9;24(10):103099. doi: 10.1016/j.isci.2021.103099. eCollection 2021 Oct 22. iScience. 2021. PMID: 34622154 Free PMC article.
-
Divalent Metal Transporter 1 Knock-Down Modulates IL-1β Mediated Pancreatic Beta-Cell Pro-Apoptotic Signaling Pathways through the Autophagic Machinery.Int J Mol Sci. 2021 Jul 27;22(15):8013. doi: 10.3390/ijms22158013. Int J Mol Sci. 2021. PMID: 34360779 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
